
Keywords: گروه پلی کامب; BCL-2; B-cell lymphoma 2; CA-125; cancer antigen-125; CAFs; cancer-associated fibroblasts; CCL17; chemokine (C-C motif) ligand 17; CCL2; chemokine (C-C motif) ligand 2; CXCL12; chemokine (C-X-C motif) ligand 12; DFS; disease-free survival; DNMT; DNA methy